SHUTTLE PHARMACEUTICALS HOLD (SHPH)
US8256932034 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2015 (2015-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 8.42M | 500.00K | 120.00K | N/A | |||
| Cash Equivalents | 2.58M | N/A | N/A | N/A | 130.00K | |||
| Marketable Securities | 2.89M | N/A | N/A | N/A | N/A | |||
| Receivables | 14.90K | N/A | 0.00 | 210.00K | 70.00K | |||
| Other Current Assets | 114.47K | 160.00K | 0.00 | 10.00K | N/A | |||
| Total Current Assets | 5.59M | 8.58M | 510.00K | 340.00K | 200.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 358.73K | 70.00K | 140.00K | 200.00K | 50.00K | |||
| Other Non-Current Assets | 0.00 | 10.00K | 10.00K | 10.00K | N/A | |||
| Total Non-Current Assets | 358.73K | 70.00K | 140.00K | 200.00K | 50.00K | |||
| TOTAL ASSETS | 5.95M | 8.65M | 650.00K | 540.00K | 250.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 690.00K | 780.00K | 570.00K | 0.00 | |||
| Current Portion Of LT Debt. | 596.00K | 0.00 | 70.00K | 60.00K | N/A | |||
| Accrued Expenses | 163.38K | 170.00K | 110.00K | 60.00K | 0.00 | |||
| Accounts Payable | 282.86K | 120.00K | 830.00K | 520.00K | N/A | |||
| Other Current Liabilities | N/A | 0.00 | 430.00K | 900.00K | N/A | |||
| Total Current Liabilities | 1.04M | 980.00K | 2.22M | 2.10M | 0.00 | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 135.09K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 718.64K | 0.00 | 60.00K | 130.00K | N/A | |||
| Total Non-Current Liabilities | 853.73K | 0.00 | 60.00K | 130.00K | N/A | |||
| TOTAL LIABILITIES | 1.90M | 980.00K | 2.28M | 2.23M | 0.00 | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -15.49M | -8.89M | -5.80M | -4.54M | -730.00K | |||
| Additional Paid In Capital | 19.54M | 16.57M | 4.15M | 2.83M | N/A | |||
| Common Shares | 160.00 | 0.00 | 20.00K | 20.00K | N/A | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 980.00K | |||
| Shares Outstanding | 16.07M | 13.60M | 13.28M | 13.28M | 49.52M | |||
| Tangible Book Value per Share | 0.25 | 0.56 | -0.12 | -0.13 | 0.01 | |||
| Total Shareholders' Equity | 4.06M | 7.68M | -1.63M | -1.69M | 250.00K | |||
| TOTAL LIABILITIES AND EQUITY | 5.95M | 8.65M | 650.00K | 540.00K | 250.00K | |||
| Statistics | ||||||||
| Debt/Equity | 0.03 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 5.37 | 8.76 | 0.23 | 0.16 | N/A | |||
| Return On Assets (ROA) | -110.77% | -35.84% | -193.85% | -168.52% | -116.00% | |||
| Return On Equity (ROE) | -162.55% | -40.36% | N/A | N/A | -116.00% | |||
All data in USD